Search results
Retirement Planning: Here's How Much To Have Saved at 60
247wallst.com· 2 days agoMany people spend decades looking forward to retirement. Retirement isn’t something that just falls...
7 Expenses That Will Drain Your Retirement Savings the Fastest
GOBankingRates via Yahoo Finance· 3 days agoYou've spent a good portion of your life working and saving for retirement. Once you reach that...
Healthy travel tips for older travelers - East Idaho News
EastIdahoNews.com· 2 days agoWhat tips can you offer retirees with health issues who are planning some trips? Before setting out,...
Op-ed: Here are 6 health-care stocks to watch now, amid a bumpy recovery
CNBC· 5 days agoHealth care, long an ailing stock market sector, has recovered over the past six months, with...
CMS final rules to boost Medicaid, CHIP access and payment: 11 things to know
Becker’s Hospital Review· 6 days agoThe AHA commended CMS for recognizing the key role hospitals play in state Medicaid financing and the importance of supplemental payments to sustain beneficiary access to ...
Most Oregonians Keeping Oregon Health Plan Coverage | Z100 Portland
iHeartRadio· 5 days agoWith more than 90 percent of the state’s 1.5 million renewals complete, more than 4 out of 5...
7 Expenses That Will Drain Your Retirement Savings the Fastest
GoBankingRates via AOL· 3 days agoYou've spent a good portion of your life working and saving for retirement. Once you reach that...
CENTENE CORPORATION REPORTS FIRST QUARTER 2024 RESULTS
WTNH-TV New Haven· 3 days ago2024 adjusted diluted EPS of $2.26, up over 7% from $2.11 in the first quarter of 2023. Increases...
The demonization of welfare
The Daily Free Press· 6 days agoActions have already been made to cut funding for other programs such as the Supplemental Nutrition Assistance Program, formerly known as food stamps, and the Housing and ...
Oppenheimer Cuts Humana (NYSE:HUM) Price Target to $370.00
ETF DAILY NEWS· 7 hours agoHumana (NYSE:HUM – Free Report) had its target price decreased by Oppenheimer from $415.00 to $370.00 in a report released on Thursday, Benzinga reports. Oppenheimer currently has an outperform ...